DIPLOMA PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,605 GBX | -0.63% |
|
+1.11% | +0.60% |
| 04-02 | RBC Lifts Diploma PT, Maintains Sector Perform Rating | MT |
| 04-02 | Bernstein starts AstraZeneca at 'outperform' | AN |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,882 | 2,742 | 3,537 | 2,894 | 4,024 | 4,862 | - | - |
| Enterprise Value (EV) 1 | 1,897 | 2,535 | 3,718 | 3,223 | 4,279 | 5,187 | 5,075 | 4,944 |
| P/E ratio | 30.4 x | 50.6 x | 50.8 x | 30.6 x | 33.2 x | 33 x | 29.1 x | 26.5 x |
| Yield | 1.74% | 1.36% | 1.5% | 2.31% | 1.88% | 1.64% | 1.72% | 1.8% |
| Capitalization / Revenue | 3.46 x | 5.09 x | 4.49 x | 2.86 x | 3.35 x | 3.56 x | 3.27 x | 3.1 x |
| EV / Revenue | 3.48 x | 4.71 x | 4.72 x | 3.18 x | 3.56 x | 3.8 x | 3.42 x | 3.15 x |
| EV / EBITDA | 18.5 x | 25.4 x | 21.9 x | 15.2 x | 16.1 x | 17.1 x | 15.4 x | 14.2 x |
| EV / FCF | 31.9 x | 33.4 x | 33.8 x | 29.4 x | 25.8 x | 30.2 x | 26.2 x | 23.7 x |
| FCF Yield | 3.13% | 3% | 2.96% | 3.4% | 3.88% | 3.31% | 3.82% | 4.23% |
| Price to Book | 5.85 x | 4.71 x | 6.6 x | 4.37 x | 4.5 x | 5.03 x | 4.61 x | 4.18 x |
| Nbr of stocks (in thousands) | 113,178 | 124,512 | 124,445 | 124,526 | 133,963 | 134,025 | - | - |
| Reference price 2 | 16.63 | 22.02 | 28.42 | 23.24 | 30.04 | 36.28 | 36.28 | 36.28 |
| Announcement Date | 19-11-18 | 20-11-16 | 21-11-22 | 22-11-21 | 23-11-20 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 544.7 | 538.4 | 787.4 | 1,013 | 1,200 | 1,366 | 1,485 | 1,571 |
| EBITDA 1 | 102.6 | 99.8 | 169.4 | 212.7 | 265.6 | 303.3 | 329.9 | 348.6 |
| EBIT 1 | 97.2 | 87.1 | 148.7 | 191.2 | 237 | 274.2 | 302.8 | 320.2 |
| Operating Margin | 17.84% | 16.18% | 18.88% | 18.88% | 19.75% | 20.07% | 20.39% | 20.39% |
| Earnings before Tax (EBT) 1 | 83.5 | 66.7 | 96.6 | 129.5 | 155.6 | 185.6 | 215.8 | 238.7 |
| Net income 1 | 61.9 | 49.3 | 69.8 | 94.7 | 117.7 | 147.6 | 166.6 | 181.1 |
| Net margin | 11.36% | 9.16% | 8.86% | 9.35% | 9.81% | 10.8% | 11.22% | 11.53% |
| EPS 2 | 0.5470 | 0.4350 | 0.5590 | 0.7590 | 0.9040 | 1.099 | 1.246 | 1.368 |
| Free Cash Flow 1 | 59.4 | 76 | 109.9 | 109.6 | 166.1 | 171.8 | 193.7 | 208.9 |
| FCF margin | 10.91% | 14.12% | 13.96% | 10.82% | 13.84% | 12.58% | 13.04% | 13.3% |
| FCF Conversion (EBITDA) | 57.89% | 76.15% | 64.88% | 51.53% | 62.54% | 56.65% | 58.72% | 59.93% |
| FCF Conversion (Net income) | 95.96% | 154.16% | 157.45% | 115.73% | 141.12% | 116.43% | 116.27% | 115.35% |
| Dividend per Share 2 | 0.2900 | 0.3000 | 0.4260 | 0.5380 | 0.5650 | 0.5946 | 0.6246 | 0.6525 |
| Announcement Date | 19-11-18 | 20-11-16 | 21-11-22 | 22-11-21 | 23-11-20 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2022 S1 | 2023 S1 |
|---|---|---|
| Net sales | 448.5 | - |
| EBITDA | - | - |
| EBIT 1 | 82.5 | 109.7 |
| Operating Margin | 18.39% | - |
| Earnings before Tax (EBT) | - | - |
| Net income | - | - |
| Net margin | - | - |
| EPS | - | - |
| Dividend per Share | - | - |
| Announcement Date | 22-05-16 | - |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 15.1 | - | 181 | 329 | 255 | 324 | 213 | 81.8 |
| Net Cash position 1 | - | 207 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.1472 x | - | 1.071 x | 1.546 x | 0.959 x | 1.069 x | 0.6458 x | 0.2346 x |
| Free Cash Flow 1 | 59.4 | 76 | 110 | 110 | 166 | 172 | 194 | 209 |
| ROE (net income / shareholders' equity) | 23.8% | 15.1% | 20% | 22.3% | 21.1% | 20.2% | 20.4% | 20.1% |
| ROA (Net income/ Total Assets) | 16.1% | 10.7% | 12.6% | 8.02% | - | - | - | - |
| Assets 1 | 385 | 460.8 | 552 | 1,181 | - | - | - | - |
| Book Value Per Share 2 | 2.840 | 4.680 | 4.310 | 5.320 | 6.680 | 7.210 | 7.880 | 8.690 |
| Cash Flow per Share 2 | 0.6200 | 0.7500 | 0.9300 | 1.000 | 1.460 | 1.560 | 1.760 | 1.880 |
| Capex 1 | 10.9 | 9.4 | 6.2 | 15.4 | 23.1 | 21.7 | 23 | 23.8 |
| Capex / Sales | 2% | 1.75% | 0.79% | 1.52% | 1.92% | 1.59% | 1.55% | 1.51% |
| Announcement Date | 19-11-18 | 20-11-16 | 21-11-22 | 22-11-21 | 23-11-20 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
36.28
GBP
Average target price
40.35
GBP
Spread / Average Target
+11.23%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.60% | 6.09B | |
| +4.89% | 38.9B | |
| +6.12% | 7.07B | |
| -9.90% | 5.14B | |
| +24.65% | 1.54B | |
| +4.47% | 1.54B | |
| -12.37% | 1.17B | |
| +4.74% | 1.09B | |
| -4.41% | 1.01B | |
| +2.00% | 957M |
- Stock Market
- Equities
- DPLM Stock
- Financials Diploma PLC
